title: Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular risk factors in patients with type 2 diabetes.
authors.affiliation: 1st Propedeutic Department Internal Medicine, AHEPA University Hospital, Thessaloniki, Greece. nikoskad@yahoo.com
authors.forename: Nikolaos P E
authors.initials: NP
authors.lastname: Kadoglou
authors.forename: Fotios
authors.initials: F
authors.lastname: Iliadis
authors.forename: Christos D
authors.initials: CD
authors.lastname: Liapis
authors.forename: Despina
authors.initials: D
authors.lastname: Perrea
authors.forename: Nikoleta
authors.initials: N
authors.lastname: Angelopoulou
authors.forename: Miltiadis
authors.initials: M
authors.lastname: Alevizos
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000209:etiology / Q000628:therapy*; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000628:therapy*; D005081:Exercise Therapy; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D012307:Risk Factors; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone